The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
.
Recent Transactions
Sort By
03-Aug-20
$110 million
Target:
Pelco Incorporated
Acquiror:
Motorola Solutions, Inc.
Advised Motorola Solutions, Inc., a global leader in mission-critical communications and analytics, on the acquisition of the Pelco Incorporated, a U.S.-based provider of video security solutions
03-Aug-20
Pending
$335 million
Target:
Range Resources Terryville Assets
Acquiror:
Castleton Resources, LLC
Advised Castleton Resources, a Houston, TX based, privately held oil and gas operator, on its acquisition of Range Resources’ Terryville Assets. As part of the transaction, Castleton Resources will change its name to “TG Natural Resources LLC” by late March 2021. Range Resources (NYSE: RRC) is a Fort Worth, TX based E&P company with primary operations in the Marcellus Shale formation.
29-Jul-20
$NA
Target:
Integrated supplier of preserved and frozen vegetables
Acquiror:
ACON Agri Investments S.L.
Advised ACON Agri Investments S.L., a special purpose vehicle of ACON Investments LLC, on the acquisition of Grupo Alsur, a leading integrated supplier of preserved and frozen vegetables with operations in Spain and Peru
02-Jul-20
Pending
$890 million
Target:
Brookfield Property Partners L.P.
Acquiror:
Brookfield Asset Management Inc.
Advised the Special Committee of Brookfield Property Partners L.P., one of the world’s premier commercial real estate companies, on its repurchase of up to $890 million of publicly held units, funded with an equity investment from Brookfield Asset Management and its affiliates
01-Jul-20
Pending
$225 million
Target:
Cello Health plc
Acquiror:
Arsenal Capital Partners
Advising Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States
10-Jun-20
Pending
$134 million
Target:
Equity stake in Bupa Arabia
Acquiror:
Bupa Ltd.
Advising Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia, the largest health insurance provider in the Kingdom of Saudi Arabia
10-Jun-20
$3.9 billion
Target:
Global collaboration agreement with Genmab A/S
Acquiror:
AbbVie, Inc
Advised AbbVie, Inc, an NYSE-listed global biopharmaceutical company, on a broad collaboration with Genmab A/S, a leading Danish-listed biotechnology company, to jointly develop and commercialise three next-generation bispecific antibody programs
09-Jun-20
Pending
$1.02 billion
Target:
LIXIL VIVA
Acquiror:
Arcland Sakamoto
Advising Arcland Sakamoto, a leading owner and operator of large home centers, on the acquisition of LIXIL VIVA, a leading owner and operator of large home centers and a listed subsidiary of LIXIL Group, a leading Japanese manufacturer of building and housing materials
03-Jun-20
Pending
$NA
Target:
Cerner RevWorks
Acquiror:
R1 RCM
Advising Cerner Corporation, a leader in healthcare information technology, on its sale of its RevWorks revenue cycle management services business to R1 RCM, a leading provider of technology-enabled RCM services
01-Jun-20
$NA
Target:
Remaining Pipe Fabrication Business
Acquiror:
N/A
Advised McDermott International, a leading provider of technology, engineering and construction solutions to the global energy industry, on the sale of the remaining Pipe Fabrication Business
30-Apr-20
$1.9bn
Target:
American Commercial Lines
Acquiror:
N.A.
Advised American Commercial Lines, a leading provider of maritime transportation services, on its pre-packaged in-court recapitalization
17-Apr-20
$NA
Target:
M&R
Acquiror:
BBB Industries
Advised Abac, a leading Iberian private equity firm, on the sale of M&R, a leading designer and distributor of aftermarket spare parts for the auto industry
06-Apr-20
$352 million
Target:
WH Smith PLC
Acquiror:
N/A
Advised WH Smith PLC, one of the UK’s leading retailers, on its £166m non pre-emptive equity placing and new £120m financing facility
23-Mar-20
Pending
$68 million
Target:
Abacus Health Products, Inc.
Acquiror:
Charlotte’s Web Holdings, Inc.
Advising Abacus Health Products, Inc., a leader in over-the-counter (“OTC”) topical products combining active pharmaceutical ingredients with cannabidiol (“CBD”) hemp extract, on its sale to the Charlotte’s Web Holdings, Inc., a market leader in hemp-derived CBD wellness products.
18-Mar-20
$NA
Target:
Centrifuge and processing equipment business of Koki Holdings Co., Ltd.
Acquiror:
Eppendorf AG
Advised Eppendorf AG, a leading family-owned life science company, on the acquisition of the centrifuge and processing equipment business of KKR-owned Koki Holdings Co., Ltd., a manufacturer of power tools and centrifuge and processing equipment
09-Mar-20
Pending
$10.6 billion
Target:
Tesco plc’s Thailand and Malaysia businesses
Acquiror:
Charoen Pokphand Group
Advising Tesco plc, a leading UK retailer, on the sale of its Thailand and Malaysia businesses to Charoen Pokphand Group, the Thai conglomerate
07-Mar-20
$148 million
Target:
KINOLT Group S.A.
Acquiror:
Rolls-Royce Power Systems AG
Advised 3i Group plc on the sale of KINOLT Group S.A., a manufacturer and supplier of dynamic uninterruptible power supply systems, to Rolls-Royce Power Systems AG, a subsidiary of Rolls-Royce Holdings plc
03-Mar-20
$NA
Target:
Formation of an incorporated joint venture
Acquiror:
BBI Group
Advised Flinders Mines, an ASX-listed mining exploration and development company, on the formation of an incorporated joint venture with BBI Group, providing a structure for the potential integrated financing and development of Flinders’ Pilbara Iron Ore Project and BBI Group’s Balla Balla rail and port infrastructure project
02-Mar-20
$NA
Target:
Global rights (excluding North America) to ThermaCare (United Kingdom)
Acquiror:
Angelini Pharma
Advised GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the global rights (excluding North America) for ThermaCare, including a dedicated manufacturing facility based in Albany, Georgia, USA, to Angelini Pharma
28-Feb-20
$NA
Target:
Rights to Three Skin Care Brands in Mexico
Acquiror:
Grisi Hnos
Advised GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the Mexico rights to Hinds, Capent and Eclipsol to Mexico-based Grisi Hnos
20-Feb-20
Pending
$NA
Target:
Asia and US rights to Physiogel
Acquiror:
LG Household & Health Care
Advising GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the rights to Physiogel Asia and the US to Korea-based LG Household & Health Care Ltd
06-Feb-20
$NA
Target:
Locaweb Serviços de Internet S.A.
Acquiror:
N/A
Advised Locaweb, a pioneer in B2B tech solutions for businesses digital transformation in Brazil with 2 main pillars: BeOnline/SaaS and Commerce
03-Feb-20
Pending
$NA
Target:
Woodward’s renewable power systems and protective relays business
Acquiror:
Aurelius Equity Opportunities
Advising Woodward, a leading designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets, on the divestiture of select assets related to its renewable power systems and protective relays businesses to Aurelius Equity Opportunities
03-Feb-20
$650 million
Target:
Clover Wireless
Acquiror:
First Lien Term Loan B Lenders
Advised Ad Hoc Group of First Lien Term Loan B Lenders on the restructuring of 4L Holdings Corporation
31-Jan-20
Pending
$NA
Target:
50:50 Joint Venture (Australian Unity)
Acquiror:
Keppel Capital Holdings
Advising Australian Unity, an Australian healthcare, financial services and retirement and living services company, on the formation of a strategic 50:50 joint venture with Keppel for investment opportunities in the Australian metropolitan office property sector